Literature DB >> 14749374

Negative control of the Myc protein by the stress-responsive kinase Pak2.

Zhongdong Huang1, Jolinda A Traugh, J Michael Bishop.   

Abstract

Pak2 is a serine/threonine kinase that participates in the cellular response to stress. Among the potential substrates for Pak2 is the protein Myc, encoded by the proto-oncogene MYC. Here we demonstrate that Pak2 phosphorylates Myc at three sites (T358, S373, and T400) and affects Myc functions both in vitro and in vivo. Phosphorylation at all three residues reduces the binding of Myc to DNA, either by blocking the requisite dimerization with Max (through phosphorylation at S373 and T400) or by interfering directly with binding to DNA (through phosphorylation at T358). Phosphorylation by Pak2 inhibits the ability of Myc to activate transcription, to sustain cellular proliferation, to transform NIH 3T3 cells in culture, and to elicit apoptosis on serum withdrawal. These results indicate that Pak2 is a negative regulator of Myc, suggest that inhibition of Myc plays a role in the cellular response to stress, and raise the possibility that Pak2 may be the product of a tumor suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749374      PMCID: PMC344192          DOI: 10.1128/MCB.24.4.1582-1594.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

Review 1.  Myc-mediated transformation: the repression connection.

Authors:  G F Claassen; S R Hann
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

2.  c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.

Authors:  M A Gregory; S R Hann
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Gene-target recognition among members of the myc superfamily and implications for oncogenesis.

Authors:  R C O'Hagan; N Schreiber-Agus; K Chen; G David; J A Engelman; R Schwab; L Alland; C Thomson; D R Ronning; J C Sacchettini; P Meltzer; R A DePinho
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

4.  c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover.

Authors:  F Bahram; N von der Lehr; C Cetinkaya; L G Larsson
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

5.  Cleavage arrest of early frog embryos by the G protein-activated protein kinase PAK I.

Authors:  R D Rooney; P T Tuazon; W E Meek; E J Carroll; J J Hagen; E L Gump; C A Monnig; T Lugo; J A Traugh
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

Review 6.  Function of the c-Myc oncogenic transcription factor.

Authors:  C V Dang; L M Resar; E Emison; S Kim; Q Li; J E Prescott; D Wonsey; K Zeller
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

7.  Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase.

Authors:  K Noguchi; C Kitanaka; H Yamana; A Kokubu; T Mochizuki; Y Kuchino
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

Review 8.  MYC oncogenes and human neoplastic disease.

Authors:  C E Nesbit; J M Tersak; E V Prochownik
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

Review 9.  New Myc-interacting proteins: a second Myc network emerges.

Authors:  D Sakamuro; G C Prendergast
Journal:  Oncogene       Date:  1999-05-13       Impact factor: 9.867

10.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  L Van Parijs; Y Refaeli; J D Lord; B H Nelson; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

View more
  31 in total

1.  Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1.

Authors:  Bor-Ruei Lin; Ven Natarajan
Journal:  Gene       Date:  2012-01-28       Impact factor: 3.688

2.  Analysis of conformational changes during activation of protein kinase Pak2 by amide hydrogen/deuterium exchange.

Authors:  Yuan-Hao Hsu; David A Johnson; Jolinda A Traugh
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

3.  Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly.

Authors:  Bin Kang; Mintie Pu; Gangqing Hu; Weihong Wen; Zigang Dong; Keji Zhao; Bruce Stillman; Zhiguo Zhang
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

4.  Silencing of CDK2, but not CDK1, separates mitogenic from anti-apoptotic signaling, sensitizing p53 defective cells for synthetic lethality.

Authors:  Tatyana S Nekova; Susanne Kneitz; Hermann Einsele; Ralf Bargou; Gernot Stuhler
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

Review 5.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

6.  Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells.

Authors:  Tatyana S Nekova; Susanne Kneitz; Hermann Einsele; Gernot Stuhler
Journal:  Cell Cycle       Date:  2014-05-20       Impact factor: 4.534

7.  Repression of SRF target genes is critical for Myc-dependent apoptosis of epithelial cells.

Authors:  Katrin E Wiese; Heidi M Haikala; Björn von Eyss; Elmar Wolf; Cyril Esnault; Andreas Rosenwald; Richard Treisman; Juha Klefström; Martin Eilers
Journal:  EMBO J       Date:  2015-04-20       Impact factor: 11.598

8.  FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.

Authors:  Zhichao Mei; Dawei Zhang; Bo Hu; Jing Wang; Xian Shen; Wuhan Xiao
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

9.  Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2.

Authors:  Jun Ling; Simon J Morley; Jolinda A Traugh
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

10.  Dose and context dependent effects of Myc on epidermal stem cell proliferation and differentiation.

Authors:  Melanie A Berta; Christopher M Baker; Denny L Cottle; Fiona M Watt
Journal:  EMBO Mol Med       Date:  2010-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.